Ardent Health Q2 FY26 net income drops 76.84% to $17 million; revenue slips 1.4% to $1.62 billion
ARDT•Quarterly results
- Ardent Health Q2 2026 revenue fell 1.4% to $1.62 billion; net income attributable to shareholders dropped to $17 million from $73 million.
- GAAP diluted EPS slid to $0.12 from $0.52; non-GAAP adjusted EBITDA fell 32.3% to $115 million.
- Operating cash flow climbed 67% to $197 million, despite a 1% decline in admissions and a 2.9% drop in total surgeries.
- Results reflected tougher year-over-year comparisons after the prior-year benefit from New Mexico state directed payments; volumes improved after an early June update.
- Reaffirmed full-year revenue guidance of $6.4 billion-$6.7 billion, maintaining non-GAAP adjusted EBITDA outlook of $485 million-$535 million.
Related News
Sysco has stopped buying iceberg lettuce from Taylor Farms and Mexico amid US cyclosporiasis outbreak, CEO says
SYY•
Suja Life Q2 net loss widens to $27.8 million; net sales rise 11.6% to $83.9 million
SUJA•
